Shots: Celltrion along with Mirae Asset has signed a contract to invest $47M into Iksuda and become its largest shareholder. The companies have completed the execution of half of the […]readmore
Tags : Acquire
Shots: PerkinElmer to acquire IDS in all cash transactions for ~$155M. The transaction is expected to be completed in Q3’21 The acquisition will allow PerkinElmer to foster its overall Diagnostics […]readmore
Shots: Kuur will receive $70M up front primarily in Athenex common stock and is eligible to receive ~$115 M as a milestone at Athenex’s sole discretion in either cash or […]readmore
Shots: Avantor to acquire Ritter and its affiliates in an all-cash transaction with an up front equity purchase price of ~ $1.06B along with additional payments following the achievement of […]readmore
Shots: DiaSorin to acquire Luminex for $37.00/ share in an all-cash transaction, with 23% premium based on closing stock price of Luminex on 24 Feb, 2021, making a total equity […]readmore
Shots: Microsoft to acquire all outstanding shares of Nuance for $56.00/ share, making a total deal value of $19.7B in cash with a premium of 23% to Nuance closing price […]readmore
Shots: Sanofi to acquire Tidal Therapeutics for $160M up front and ~ $310M following the achievement of certain milestones The acquisition will add Tidal’s innovative mRNA-based research platform with applications […]readmore
Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will […]readmore
Shots: ACEA to receive up to ~$38M in shares of Sorrento common stock, $450M as additional payments upon the achievement of clinical & sales milestones along with 5 – 10% […]readmore
Shots: ADQ to acquire all the outstanding shares of Amoun Pharmaceutical from Bausch Health for ~$740M. The transaction is expected to close in H1’21 The divestiture is part of its […]readmore